Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model.
D000284:Administration, Oral; D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004481:Ectromelia virus / Q000187:drug effects; D004482:Ectromelia, Infectious / Q000188:drug therapy*; D004952:Esters / Q000737:chemistry / Q000627:therapeutic use; D005260:Female; D020128:Inhibitory Concentration 50; D051379:Mice; D015394:Molecular Structure; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000737:chemistry / Q000627:therapeutic use*
D000998:Antiviral Agents; D004952:Esters; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir